Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease.

Bryksin AV, Godfrey HP, Carbonaro CA, Wormser GP, Aguero-Rosenfeld ME, Cabello FC.

Clin Diagn Lab Immunol. 2005 Aug;12(8):935-40.


Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York.

Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L, Jacob J, Frey M, Noto R, Carbonaro CA, Wormser GP.

J Clin Microbiol. 2002 Jul;40(7):2612-5.


Effects of OspA vaccination on Lyme disease serologic testing.

Aguero-Rosenfeld ME, Roberge J, Carbonaro CA, Nowakowski J, Nadelman RB, Wormser GP.

J Clin Microbiol. 1999 Nov;37(11):3718-21.


Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium.

Montecalvo MA, Horowitz H, Wormser GP, Seiter K, Carbonaro CA.

Antimicrob Agents Chemother. 1995 Mar;39(3):794. No abstract available.


Serodiagnosis in early Lyme disease.

Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP.

J Clin Microbiol. 1993 Dec;31(12):3090-5. Erratum in: J Clin Microbiol 1994 Mar;32(3):860.


Inhibition of the Salmonella typhi oral vaccine strain, Ty21a, by mefloquine and chloroquine.

Horowitz H, Carbonaro CA.

J Infect Dis. 1992 Dec;166(6):1462-4. No abstract available.


A bacterial pathogenicity determinant associated with necrotizing enterocolitis.

Carbonaro CA, Clark DA, Elseviers D.

Microb Pathog. 1988 Dec;5(6):427-36.


Supplemental Content

Loading ...
Support Center